Xla1
Showing 1 - 10 of 10
Obesity, Metabolic Disease Trial in Lincoln (Xla1, Placebo)
Completed
- Obesity
- Metabolic Disease
- Xla1
- Placebo
-
Lincoln, NebraskaCelerion
Jul 12, 2021
Common Variable Immunodeficiency and Related Syndromes
Recruiting
- CVID
- XLA
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
COVID-19 Vaccine Responses in PIDD Subjects
Recruiting
- X-linked Agammaglobulinemia
- +6 more
-
Saint Petersburg, Florida
- +2 more
Apr 7, 2022
Gastroesophageal Reflux, Functional Dysphonia Trial in Beijing (Tongjiang granule, Tongjiang granule simulant)
Recruiting
- Gastroesophageal Reflux
- Functional Dysphonia
- Tongjiang granule
- Tongjiang granule simulant
-
Beijing, Beijing, ChinaXiyuan Hospital of China Academy of Chinese Medical Sciences
Apr 1, 2022
Primary Immunodeficiency Disease Trial (Boya IVIG)
Not yet recruiting
- Primary Immunodeficiency Disease
- Boya IVIG
- (no location specified)
Nov 21, 2023
COVID-19 Trial in Beijing (Traditional Chinese Medicine Prescription)
Unknown status
- COVID-19
- Traditional Chinese Medicine Prescription
-
Beijing, Beijing, ChinaHao Li
Mar 24, 2020
Cognitive Dysfunction Trial in Beijing (Gulingji capsules, Ginko Biloba Extract tablet)
Unknown status
- Cognitive Dysfunction
- Gulingji capsules
- Ginko Biloba Extract tablet
-
Beijing, Beijing, ChinaLi Hao
Aug 23, 2018
Primary Immune Deficiency Disease Trial in United States (Flebogamma 5% DIF)
Completed
- Primary Immune Deficiency Disease
- Flebogamma 5% DIF
-
St. Petersburg, Florida
- +6 more
Dec 7, 2016
Common Variable Immunodeficiency, Agammaglobulinemia Trial in Worldwide (Vivaglobin)
Completed
- Common Variable Immunodeficiency
- Agammaglobulinemia
-
Edmonton, Alberta, Canada
- +5 more
Jun 12, 2013